Ages 19-39 Years: Laboratory and Other Tests

Jump to:
Ages 19-39
     Evaluation and counseling


□ Cervical cytology:

  • Age 21-29 years: Screen every 3 years with cytology alone
  • Age 30 years and older: Preferred--Co-test with cytology and HPV testing every 5 years;  Option--Screen with cytology alone every 3 years
  • Age 25 years and older: the FDA-approved primary HPV screening test can be considered as an alternative to current cytology-based cervical cancer screening methods.

Chlamydia and gonorrhea testing (if female is 24 years and younger and sexually active)
□ Genetic testing/counseling (screening for spinal muscular atrophy, cystic fibrosis carrier, and assessment for risk of a hemoglobinopathy should be offered to all women who are considering pregnancy)
□ Human immunodeficiency virus (HIV) testing - Physicians should be aware of and follow  their states' HIV screening requirements. Visit the Centers for Disease Control and  Prevention for more information.


High-Risk Groups (See High-Risk Table for more information)

□ Bone mineral density screening
□ Colorectal cancer screening
□ Diabetes testing
□ Genetic testing/counseling (fragile X syndrome, Tay–Sachs disease) 
□ Hemoglobin level assessment
□ Hepatitis C virus testing
□ Lipid profile assessment
□ Mammography
□ Sexually transmitted infection testing
□ Thyroid-stimulating hormone testing
□ Tuberculosis skin testing

American College of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188
Mailing Address: PO Box 96920, Washington, DC 20024-9998